Cero Therapeutics Holdings CERO
OTC CERO
$0.00 -0.01 (-100.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Cero Therapeutics Holdings, Inc. (CERO) Income towards Parent Company (2022 - 2026)

Updated

Cero Therapeutics Holdings' Income towards Parent Company was -$1.03 million in Q2 2026, compared with -$5.42 million a year earlier.

Analysis

Cero Therapeutics Holdings, Inc. (CERO) Income towards Parent Company (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cero Therapeutics Holdings' Income towards Parent Company was -$16.31 million through Jun 30, 2026; for FY2025, it was -$19.92 million.

  • In earlier years, Income towards Parent Company was -$7.73 million in FY2024, -$7.29 million in FY2023, -$667,736 in FY2022 and -$315,547 in FY2021.
  • The Q2 2026 figure marks the highest quarterly Income towards Parent Company since Q4 2024.
  • Per Business Quant data, CERO's Income towards Parent Company in the three quarters before Q2 2026 was -$5.89 million (Q1 2026), -$4.54 million (Q4 2025) and -$4.86 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.03 Mn
Mar 31, 2026 -5.89 Mn
Dec 31, 2025 -4.54 Mn
Sep 30, 2025 -4.86 Mn
Jun 30, 2025 -5.42 Mn
Mar 31, 2025 -5.11 Mn
Dec 31, 2024 671,892.00
Sep 30, 2024 -4.23 Mn
Jun 30, 2024 -2.45 Mn
Mar 31, 2024 -1.73 Mn
Dec 31, 2023 -1.27 Mn
Sep 30, 2023 -1.35 Mn
Jun 30, 2023 -2.09 Mn
Mar 31, 2023 -2.44 Mn
Dec 31, 2022 -262,675.00
Sep 30, 2022 84,505.00
Jun 30, 2022 -111,569.00
Mar 31, 2022 -377,997.00
API Access

Cero Therapeutics Holdings, Inc. Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=CERO&period=max&api_key=YOUR_API_KEY